Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VTL

Vital Therapies (VTL) Stock Price, News & Analysis

Vital Therapies logo

About Vital Therapies Stock (NASDAQ:VTL)

Advanced Chart

Key Stats

Today's Range
$0.68
$0.75
50-Day Range
$0.83
$14.50
52-Week Range
$0.15
$9.75
Volume
1.05 million shs
Average Volume
21.62 million shs
Market Capitalization
$30.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.

Receive VTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vital Therapies and its competitors with MarketBeat's FREE daily newsletter.

VTL Stock News Headlines

Fuel from trash? Texas startup turns waste into cash flow
Plastic waste isn't just an environmental issue - it's becoming a public health emergency. Microplastics have been found in human blood, breastmilk, and even placental tissue. And with 151,000 tons of plastic waste now stranded onshore due to export bans, landfills are overwhelmed and municipalities are scrambling for alternatives. One U.S. company may have found the answer.
Lighthouse Center for Vital Living celebrates new building
Vardhman Textiles Ltd.
See More Headlines

VTL Stock Analysis - Frequently Asked Questions

Vital Therapies, Inc. (NASDAQ:VTL) released its quarterly earnings data on Tuesday, August, 7th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.03.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vital Therapies investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Endologix (ELGX), Anthera Pharmaceuticals (ANTH), Bristol Myers Squibb (BMY), Novavax (NVAX) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
8/07/2018
Today
6/23/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VTL
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$41.47 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
2.48

Miscellaneous

Free Float
N/A
Market Cap
$30.51 million
Optionable
Not Optionable
Beta
3.51
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:VTL) was last updated on 6/24/2025 by MarketBeat.com Staff
From Our Partners